Pharmacokinetic profile of an oral loading dose of divalproex sodium during acute alcohol withdrawal [12]

Journal of Clinical Psychopharmacology

Volumn 26, Issue 1, 2006, Pages 105-107

  Reoux, Joseph P ^a   Saxon, Andrew J ^a   Shen, Danny ^b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; OXAZEPAM; PROCHLORPERAZINE; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; ALCOHOL WITHDRAWAL; BLOOD SAMPLING; CASE REPORT; DIZZINESS; DRUG BLOOD LEVEL; GAS CHROMATOGRAPHY; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; MALE; MASS SPECTROMETRY; PATIENT SELECTION; PRIORITY JOURNAL; SCORING SYSTEM; SOMNOLENCE; VOMITING;

ADMINISTRATION, ORAL; ANTICONVULSANTS; ETHANOL; HUMANS; MALE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; VALPROIC ACID;

EID: 31544436586     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000196416.06729.fe     Document Type: Letter

References (11)

1. Sullivan JT, Sykora K, Schniederman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84:1353-1357.
2. Semmes RL, Shen DD. Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins. Pharm Res. 1990;7:461-467.
3. Malcolm R, Myrick H, Brady KT, et al. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict. 2001;10(suppl):16-23.
4. Gentry JR, Hill C, Malcolm R. New anticonvulsants: a review of applications for the management of substance abuse disorders. Ann Clin Psychiatry. 2002;14(4):233-245.
5. Bonnet U, Banger M, Leweke FM, et al. Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial. J Clin Psychopharmacol. 2003;23:514-519.
6. Reoux JP, Saxon AJ, Malte CA, et al. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo controlled trial. Alcohol Clin Exp Res. 2001;25(9): 1324-1329.
7. Bowden CL, Janicak PG, Orsulak P, et al. Relation of serum valproate concentration to response in mania. Am J Psychiatry. 1996;153:765-770.
8. USP DI® Drug Information for the Health Care Professional. 23rd ed. Englewood, CO: The United States Pharmacopeial Convention, MICROMEDEX; 2003.
9. Longo LP, Campbell T, Hubatch S. Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. J Addict Dis. 2002;21(2):55-64.
10. Martinez JM, Russell JM, Hirshfield RMA. Tolerability of oral loading of divalproex sodium in the treatment of acute mania. Depress Anxiety. 1998;7:83-86.
11. Lima WJ, Dopheide JA, Kramer BA, et al. A naturalistic comparison of adverse effects between slow titration and loading of divalproex sodium in psychiatric inpatients. J Affect Disord. 1999;52:261-267.